Heparin resistance and Marfan syndrome: is there any correlation?

Minati Choudhury,U. Kiran,N. Saxena,R. Saxena

DOI: https://doi.org/10.1053/JCAN.2002.29687

IF: 2.894

2002-02-01

Journal of Cardiothoracic and Vascular Anesthesia

Abstract:MARFAN SYNDROME is an autosomal disorder of connective tissue with variable manifestations primarily involving the cardiovascular, musculoskeletal, and ocular systems.1 It is serious because of its cardiovascular complications.2 The most striking cardiovascular lesions are progressive dilation of the aortic root with a resultant ascending aortic aneurysm and aortic valve incompetence. Replacement of the aneurysmal aorta with a prosthetic graft prolongs the life expectancy in patients with Marfan syndrome. Cardiopulmonary bypass (CPB) is necessary, and profound hypothermia and total circulatory arrest are often required for this procedure. Heparin has been used as the anticoagulant of choice since 1953, and activated coagulation time (ACT) is the most common intraoperative test to monitor heparin anticoagulation during extracorporeal circulation.3-7 Infrequently, a large amount of heparin may be necessary to prolong the ACT to 400 seconds. This condition is known as heparin resistance, the definite cause of which has not been well understood.8-11 Heparin resistance was observed in 3 patients with Marfan syndrome who underwent surgery for the associated aortic aneurysm. Of the 3 patients, 1 patient had antithrombin III (AT III) deficiency, whereas in the other 2 the level of this protein was found to be normal. The authors posed the question: Is there any association between heparin resistance and Marfan syndrome?